Navigation Links
CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
Date:11/26/2007

BRANFORD, Conn., Nov. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, and TopoTarget A/S (Copenhagen Stock Exchange: TOPO) announced today that updated preliminary clinical trial results from the Phase II study of belinostat for T-cell lymphomas, and new preclinical data evaluating belinostat on pediatric leukemia cell lines, will be presented at the 2007 American Society of Hematology (ASH) 49th Annual Meeting in Atlanta, GA, on Monday, December 10, 2007.

The presentation details are as follows:

Title: Belinostat (PXD101) in Patients with Recurrent or Refractory

Peripheral or Cutaneous T-Cell Lymphoma: Results of a Phase

II Study

Date/Time: Monday, December 10, 2007, 5:00 - 7:00 PM EST

Session: Lymphoma: Chemotherapy, excluding Pre-Clinical Models-

Diffuse Large Cell Lymphoma and T-Cell Lymphoma

Poster board: 672-II

Abstract: 3453

Title: Investigation of the Efficacy of PXD101 (Belinostat) on

Primary Leukaemic Cells and Cell Lines as a Novel Agent for

Childhood Acute Lymphoblastic Leukaemia (ALL)

Date/Time: Monday, December 10, 2007, 5:00 - 7:00 PM EST

Session: Acute Lymphocytic Leukemia: Biology and Pathophysiology

Poster board: 12-III

Abstract: 2793

These abstracts are currently available online at http://www.abstracts2view.com/hem07. Following their presentation on December 10, 2007, reprints of the posters will be made available on CuraGen's website at '/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT...3yearsfollowinganautoaccident,wasactuallyfullycons...MorningAmericasegment.TheDynaVoxEyeMaxwasfeaturedi...omeandotherconditionscanunlockcommunication. ,,...lableonlineat www.dynavoxtech.com ,, WHO...
(Date:11/24/2009)...,, FREMONT,Calif.,Nov.24/PRNewswire-FirstCall...dtheCompanyfileditsPlanofReorganizationandDisclosu...esBankruptcyCourtfortheDistrictofDelaware.Ahearing...tlyscheduledforDecember8,2009,withthehearingonthec..., ThePlancallsfortheCompanytopayallclaimsinfull.T...
(Date:11/24/2009)...,, POTOMAC,Md.,Nov.24/PRNewswire/--Inaddition...skihasaddedPhiladelphiajurorstoherThanksgivinggrat...hoice.Iamsothankfultothem,"shesaidofMonday,sverdic...uticals. ,, Wisneskiisamong12,000womennationwid...thehormonetherapydrugsPremarinandPrempro.Wisneskia...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Atlanta based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Fa 4903 1Atlanta based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Fa 4903 2Atlanta based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Fa 4903 3Free Seminars Will Detail Best Practices in Employer Hearing Conservation Impending NRR Change 55417 1Free Seminars Will Detail Best Practices in Employer Hearing Conservation Impending NRR Change 55417 2Free Seminars Will Detail Best Practices in Employer Hearing Conservation Impending NRR Change 55417 3Free Seminars Will Detail Best Practices in Employer Hearing Conservation Impending NRR Change 55417 4Twenty Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 55413 1Twenty Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 55413 2
...inical Data Presented at American Pain Society Ann...utics, Inc., a venture backed clinical stage biote...ay announced the presentation of data demonstratin... reduced pain caused by diabetic neuropathy in a d...t will be presented in a poster session on May 8th...
...dy Results Demonstrated Significant Weight Loss in...IEW, Calif., May 7 VIVUS, Inc. (Nasdaq: VVUS ),...lopment and commercialization of novel therapeutic...iously reported 28-week phase 3 EQUATE trial of Qn...y at the 17th annual European Congress on Obesity ...
Other Medicine Technology:Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 2Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 3Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity 2Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity 3Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity 4
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheBayAreaAirQualityManagemen... the Air Alert forThursday,November26,2...thersolidfuel,bothindoorsandoutdoors. ,, "Cold,...orrow,"saidJackBroadbent,executiveofficeroftheAirD...althoftheirneighborsandfellowcommunitymembersthisT...
(Date:11/25/2009)...ound evidence of a statistically significant survi... whose estrogen receptor (ER)-positive tumors had ...ine-118 (ER-alpha S118-P), according to a brief co...ournal of the National Cancer Institute . , Appr...o tamoxifen. Preclinical studies have shown that E...
(Date:11/25/2009)...period was too short to draw definite conclusions,...ealthDay News) -- In diabetic patients with blocke...ence in outcomes at one year whether patients unde...ritish researchers report. , Bypass surgery has... with coronary artery disease. However, less invas...
(Date:11/25/2009)...ss could lead mothers to overlook needed care, stu...ay News) -- A mother,s depression can worsen her c...heir six-month study of 262 black mothers and thei...ore depressive symptoms had more frequent asthma s...essive symptoms had less frequent asthma symptoms....
(Date:11/25/2009)...25/PRNewswire/-- MISSIONSkincare ®isproudtosu...e.AspartofGNC,sannualSt.Jude ThanksandGiving campa...s new SUPER-C(TM)LipBalm willbedonatedtoSt.Jude....$1,$5or$10donationatcheckoutatoneoftheir5,000+reta...llionforSt.Judeduringtheir2009 ThanksandGiving cam...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...cently performed for the first time in the United ...mbolysis to destroy a deadly blood clot in a pati...he procedure was performed by Abbas Chamsuddin, MD...ins of the patient's leg, pelvis and inferior vena...
...e sleep problems than children from middle class f...rformance at school, according to research. ...althy inner city children, who were African Americ...o fill out a survey, which examined amount of slee...
...aring loss in the US has climbed steadily in recen...f them do not turn up for follow-up evaluation the...lopment that they might never overcome, says autho...ened for hearing loss each year, according to the ...
...ardiac) chest pain is often severe, driving many p... despite the fact that the ailment has no definabl...mes be the result of acid reflux disease, when thi...ms. The study finds that theophylline, tak...
...and large-scale genetic differences between humans... a wide range of diseases, according to a paper by... Eichler and 17 colleagues published in the May 10... ten percent of the human genome. Past st...
...friend and buried her under a house in Perth were ...cant be let out on prole till they are in their th...amed because of their age, pleaded guilty in March...less in the extreme". During lengthy sente...
Other Medicine News:Health News:First Ultrasound Thrombolysis in U.S. Performed at Emory University Hospital 2Health News:Experts Stress Need for Follow-up Evaluation of Children Who Fail Hearing Loss Screening 2Health News:Cataloging the Structural Variations in Human Genetics 2Health News:Cataloging the Structural Variations in Human Genetics 3Health News:Two Australian Teenagers Sentenced to Life for Murder 2
...orporate a layered design unique in the industry. ...ent stray electrosurgical burns along the shaft of...pacitive coupling; a well-documented patient safet...nstruments provides a neutral return path for capa...
...orporate a layered design unique in the industry. ...ent stray electrosurgical burns along the shaft of...pacitive coupling; a well-documented patient safet...nstruments provides a neutral return path for capa...
...orporate a layered design unique in the industry. ...ent stray electrosurgical burns along the shaft of...pacitive coupling; a well-documented patient safet...nstruments provides a neutral return path for capa...
...single-use laparoscopic fan retractor has applicat... for endoscopic surgery and may be used as an alte...ingle-use J-shaped laparoscopic fan retractor is d...ture™ Laparolift™ arm for retracting t...
Medicine Products: